[Description]: the product can be used with Bioda immune detector to quantitatively detect creatine kinase isoenzyme MB in human whole blood, serum and plasma, and it can provide the reference for clinical diagnosis of myocardial infarction.
 
[Detailed information]: Bioda CKMB produced by our company is an in-vitro diagnostic reagent used to detect CKMB protein in human whole blood, serum and plasma.  

The creatine kinase contains three isoenzymes, and it is a dimer consisting of two types of monomers, while it exists in three different forms: CK-MM (muscular form), CK-MB (myocardial form), CK-BB (brain form). MB isoenzyme accounts for about 15-20% of the total CK, and only exists in cardiac muscle tissue, which makes itself have diagnostic value and become valuable marker for diagnosing myocardial damage. The existence of CK-MB in serum indicates that the myocardial damage is suspected. The monitoring of CK-MB is very important for the diagnosis of myocardial ischemia. For acute myocardial infarction and myocarditis, CK-MB will rise in 3-8h of chest pain.   

[Reaction time]: 12min
[Detection range]: 1-60ng / ml
[Clinical significance]: diagnosis of myocardial loss and myocarditis
[Application departments]: Outpatient Department, Emergency Department, Cardiology Department, Thoracic Surgery Department, Ambulance, Ward, ICU, Geriatrics Department

[Interpretation method]: